Expression profile of genes coding for melanoma differentiation antigens and cancer/testis antigens in metastatic lesions of human cutaneous melanoma

Melanoma Research

Volumn 11, Issue 5, 2001, Pages 451-459

  Zendman, A J W ^a   De Wit, N J W ^a   Van Kraats, A A ^a   Weidle, U H ^b   Ruiter, D J ^a   Van Muijen, G N P ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ROCHE DIAGNOSTICS GMBH   (Germany)

Author keywords

Cancer testis antigen; Differentiation; Expression; Immunotherapy; Melanoma metastases

Indexed keywords

DIFFERENTIATION ANTIGEN; MESSENGER RNA; TUMOR ANTIGEN;

ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ARTICLE; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MELANOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN METASTASIS; T LYMPHOCYTE;

ANTIGENS, NEOPLASM; CELL DIFFERENTIATION; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; NEOPLASM METASTASIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SKIN NEOPLASMS; TESTIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0034771435     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-200110000-00003     Document Type: Article

References (38)

1. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma
2. A new era for cancer immunotherapy based on the genes that encode cancer antigens
3. Tumor antigens discovery: Perspectives for cancer therapy
4. Structure, chromosomal localization, and expression of 12 genes of the MAGE family
5. BAGE: A new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes
6. Characterization of the GAGE genes that are expressed in various human cancers and in normal testis
7. A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening
8. SSX: A multigene family with several members transcribed in normal testis and human cancer
9. XAGE-1, a new gene that is frequently expressed in Ewing's sarcoma
10. Identification of multiple cancer/testis antigens by allogeneic antibody screening of a melanoma cell line library
11. Identification of a new MAGE gene with tumor-specific expression by representational difference analysis
12. Expression of cancer-testis antigens in lung cancer: Definition of bromodomain testis-specific gene (BRDT) as a new CT gene, CT9
13. CT10: A new cancer-testis (CT) antigen homologous to CT7 and the MAGE family, identified by representational-difference analysis
14. CTp11, a novel member of the family of human cancer/testis antigens
15. Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3
16. Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma
17. Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma
18. Identification of new melanoma epitopes on melanosomal proteins recognized by tumor infiltrating T lymphocytes restricted by HLA-A1, -A2, and -A3 alleles
19. New cancer therapy by immunomanipulation: Development of immunotherapy for human melanoma as a model system
20. Analysis of expression of the melanoma-associated antigens MART-1 and gp100 in metastatic melanoma cell lines and in in situ lesions
21. Heterogeneous expression of immunotherapy candidate proteins gp100, MART1, and tyrosinase in human melanoma cell lines and in human melanocytic lesions
22. Comparative analysis of the in vivo expression of tyrosinase, MART-1/Melan-A, and gp100 in metastatic melanoma lesions: Implications for immunotherapy
23. A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma
24. Antigens recognized by T-lymphocytes on human tumours
25. Expression of multiple cancer/testis (CT) antigens in breast cancer and melanoma: Basis for polyvalent CT vaccine strategies
26. Epression of SSX genes in human tumors
27. Molecular detection of tumor-associated antigens shared by human cutaneous melanomas and gliomas
28. High homogeneity of MAGE, BAGE, GAGE, tyrosinase and Melan-A/MART-1 gene expression in clusters of multiple simultaneous metastases of human melanoma: Implications for protocol design of therapeutic antigen-specific vaccination strategies
29. Heterogeneous expression of the SSX cancer/testis antigens in human melanoma lesions and cell lines
30. Genes encoding tumor-specific antigens are expressed in human myeloma cells
31. Melanoma-associated antigens as messenger RNA detection markers for melanoma
32. Immunophenotyping of melanomas for tyrosinase: Implications for vaccine development
33. Expression of MAGE genes in primary and metastatic cutaneous melanoma
34. Monoclonal antibody 57B stains tumor tissues that express gene MAGE-A4
35. LAGE-1, a new gene with tumor specificity
36. NY-ESO-1 tumour associated antigen is a cytoplasmic protein detectable by specific monoclonal antibodies in cell lines and clinical specimens
37. Expression of MAGE-antigens in normal tissues and cancer
38. MAGE-3 immunoreactivity in formalin-fixed, paraffin-embedded primary and metastatic melanoma: Frequency and distribution